Incidence of acute leukemia in pregnancy is extremely low, symptoms overlap with gestation, and delayed diagnosis amplifies the need for coordinated hematology–maternal-fetal management. A 23-patient ...
For acute lymphoid and AML, MFC MRD is the most accessible assay that is also sensitive, specific, with a rapid turnaround time. Detection of molecular MRD in pediatric ALL and AML is dependent on the ...
Treatment for Acute Lymphocytic Leukemia (ALL) primarily involves chemotherapy, divided into three phases: induction (to achieve remission), consolidation (to eliminate remaining cancer cells), and ...
Credit: Getty Images ALL is the most common childhood cancer, and cases are rising. Find out why this trend is paired with a remarkable 90% survival rate, and what public health action is needed next.
A new generation of targeted treatments and gentler chemotherapy options for older adults with a new diagnosis of acute myeloid leukemia (AML) is driving better survival and cure rates. Led by Mikkael ...
Acute myeloid leukemia (AML) is a type of blood and bone marrow cancer. AML can affect people of any age, but it is most common in adults. AML occurs when bone marrow produces abnormal blood cells, ...
Secondary acute myeloid leukemia (AML) is a blood cancer that arises from other blood disorders or previous cancer treatment. Those with secondary AML tend to have a less favorable outlook than those ...
Researchers at The University of Texas MD Anderson Cancer Center have discovered a new way in which T cells attack acute ...
Preclinical study results suggest that targeting Hippo signaling may help address treatment resistance in acute myeloid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results